Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Common Equity (2016 - 2025)

Prestige Consumer Healthcare has reported Common Equity over the past 16 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly results put Common Equity at $1.8 billion for Q4 2025, up 2.29% from a year ago — trailing twelve months through Dec 2025 was $1.8 billion (up 2.29% YoY), and the annual figure for FY2025 was $1.8 billion, up 10.86%.
  • Common Equity for Q4 2025 was $1.8 billion at Prestige Consumer Healthcare, roughly flat from $1.8 billion in the prior quarter.
  • Over the last five years, Common Equity for PBH hit a ceiling of $1.9 billion in Q2 2025 and a floor of $1.4 billion in Q1 2021.
  • Median Common Equity over the past 5 years was $1.6 billion (2022), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Common Equity: increased 16.15% in 2022 and later dropped 8.27% in 2023.
  • Prestige Consumer Healthcare's Common Equity stood at $1.5 billion in 2021, then grew by 11.1% to $1.7 billion in 2022, then decreased by 5.12% to $1.6 billion in 2023, then rose by 11.74% to $1.8 billion in 2024, then increased by 2.29% to $1.8 billion in 2025.
  • The last three reported values for Common Equity were $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025) per Business Quant data.